New PROSPER Data Demonstrate Real-World Impact of Mogamulizumab on Symptoms and Health-Related Quality of Life in Mycosis Fungoides and Sézary Syndrome

New PROSPER Data Demonstrate Real-World Impact of Mogamulizumab on Symptoms and Quality of Life in Mycosis Fungoides and Sézary Syndrome

Posted by GlobeNewswire on June 29, 2026

-------- Original Version -----------

New PROSPER Data Demonstrate Real-World Impact of Mogamulizumab on Symptoms and Health-Related Quality of Life in Mycosis Fungoides and Sézary Syndrome

-------- English Version ------------

New PROSPER Data Demonstrate Real-World Impact of Mogamulizumab on Symptoms and Health-Related Quality of Life in Mycosis Fungoides and Sézary Syndrome

-------- Link if available ----------

No Link available